Payer-driven access
Formulary inclusion is now harder than regulatory approval. Even cleared therapies stall on reimbursement decisions.
Industries · Life Sciences & Healthcare
Clinicians don’t take surveys. Researchers don’t follow funnels.
We reach them anyway.
Life sciences and healthcare research demands access generalist platforms cannot provide — verified clinicians, biotech researchers, KOLs, payers, and patients, credential-checked before they enter a study.
Industry Challenges
The strategic challenges
this sector faces.
Real-world evidence demand
Clinical trial data alone no longer satisfies payers, regulators, or KOLs. RWE expectations rise faster than infrastructure.
Patient voice in protocol design
Regulators increasingly require patient input in trial design. Sponsors aren't sure how to capture it credibly.
Our Life Sciences & Healthcare Community
Audiences that shape
life sciences & healthcare decisions.
From the bench scientist to the bedside clinician, the payer to the patient — six audiences across the value chain, every member credential-verified before any study begins.
Specialist
Specialist Physicians
Cardiologists, oncologists, neurologists, and 15+ other specialisations. Active practitioners with verified hospital affiliations.
GP
General Practitioners & GPs
Urban and semi-urban primary care physicians — the frontline of prescription and patient management decisions.
Researcher
Biotech & Clinical Researchers
Bench scientists, R&D leads, and clinical trial investigators across pharma, biotech, and academic medical centres.
KOL
Key Opinion Leaders
Discipline-defining KOLs with publication records, conference presence, and institutional authority — the voices that move guidelines.
Payer
Payers & Hospital Administrators
Insurance medical directors, hospital procurement heads, and medical superintendents — the gatekeepers of access and reimbursement.
Pharma
Patient Communities
Condition-specific patient groups — oncology, diabetes, cardiovascular, rare disease — verified through diagnosis documentation, with consent-aware research design.
Research Applications
What our Life Sciences & Healthcare
research powers.
Six decisions every life sciences and healthcare team faces — therapy, trial, payer, patient. The research design that closes each one.
Therapy Awareness & Adoption
Physician awareness, perception, and prescribing intent for new or existing therapies — across specialisations and geographies.
Clinical Trial Feasibility
Investigator interest, site readiness, and patient recruitment potential — before committing trial infrastructure investment.
Hospital & Payer Procurement
Vendor evaluation, formulary inclusion, and reimbursement pathways across private and public payers.
Patient Journey Mapping
Diagnosis-to-treatment pathway across conditions — friction points, unmet needs, adherence drivers, real-world experience.
Medical Device & MedTech Studies
Adoption, switching, and substitution dynamics for diagnostic, surgical, and digital health platforms across care settings.
Health Policy & Public Health
Population-level health attitude and behaviour research for government, NGO, and institutional clients requiring nationally representative data.
How We Help
Research solutions tailored
for Life Sciences & Healthcare.
Each solution is designed around how this sector actually makes decisions — the right audience, the right methodology, and the right analytical frame for the call you face.
✓
Payer Access Research
Decode formulary criteria, reimbursement levers, and evidence requirements across public and private payers.
✓
Real-World Evidence Studies
Patient-reported outcomes, treatment patterns, and adherence drivers — fielded with clinical-grade rigour.
✓
Patient Voice in Protocol Design
Regulatory-grade patient input on burden, endpoints, and consent — verified through diagnosis documentation.
The clinical recommendation is upstream of every patient outcome.
Case Study
Intelligence in action.
A real brief. A real outcome.
CLIENT CASE STUDY — LIFE SCIENCES & HEALTHCARE
A Global Pharmaceutical Major
Objective
Understand oncologist treatment decision frameworks and barriers to adoption of a newly approved targeted therapy across 6 Indian metros.
Approach
120 specialist oncologist IDIs conducted via CATI with our verified KOL network. Supplemented by 400 online surveys among treating physicians across urban and semi-urban centres.
Outcome
Identified 3 adoption barriers and 2 unmet clinical needs that reshaped the brand's medical education and sales-rep briefing strategy — measurable Rx uplift in two quarters.
Why Robin & Berry
The research partner
Life Sciences & Healthcare needs
looks different.
Sector-Specific Audience Depth
Verified by role, sector, and active engagement — not stitched from a generic database. Each panel built around how decisions actually flow in this sector.
5-Stage Quality Validation
Every response passes through our Validation Intelligence Loop before it reaches your dataset. Quality Certificate provided with every deliverable.
2-Hour Response Guarantee
A senior sector specialist responds to every brief within 2 hours — with a proposed approach, not just an acknowledgement email.
Continue exploring
Brief us
Life Sciences research that reaches the clinician behind the decision.
Brief our Life Sciences & Healthcare research specialists. We'll design the right audience, methodology, and quality architecture for your decision — within 2 hours.